(SLGN) Silgan Holdings - Ratings and Ratios
Dispensing Closures, Metal Cans, Custom Plastic Containers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.71% |
| Yield on Cost 5y | 2.35% |
| Yield CAGR 5y | 9.33% |
| Payout Consistency | 45.7% |
| Payout Ratio | 20.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 25.7% |
| Value at Risk 5%th | 38.2% |
| Relative Tail Risk | -9.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -28.74 |
| CAGR/Max DD | -0.15 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | 0.650 |
| Beta Downside | 0.560 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.70% |
| Mean DD | 13.80% |
| Median DD | 13.91% |
Description: SLGN Silgan Holdings January 08, 2026
Silgan Holdings Inc. (NYSE: SLGN) manufactures rigid packaging solutions for consumer-goods manufacturers in the U.S. and abroad, operating through three segments: Dispensing & Specialty Closures, Metal Containers, and Custom Containers.
The Dispensing & Specialty Closures segment supplies proprietary metal and plastic closures, capping equipment, and fragrance-detection systems to the food, beverage, personal-care, and home-care markets. The Metal Containers business produces steel and aluminum cans for pet food, soups, proteins, and other shelf-stable foods, while the Custom Containers segment offers high-density polyethylene (HDPE) and PET trays, thermoformed bowls, and specialty plastic fitments for both food and household products. Sales are driven primarily by a direct sales force, supplemented by distributors and an online catalog.
In FY 2023 Silgan reported revenue of roughly $2.5 billion with an adjusted EBITDA margin near 10%, reflecting modest pricing power but sensitivity to raw-material costs (steel, aluminum, resin). Key economic drivers include food-price inflation, which boosts demand for durable metal cans, and the continued shift toward e-commerce packaging that favors high-volume, low-cost closures. The company’s exposure to commodity price volatility and its ability to pass through cost increases remain central to earnings outlook.
For a deeper quantitative view of SLGN’s valuation metrics, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 339.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.46 > 1.0 |
| NWC/Revenue: 9.59% < 20% (prev 3.70%; Δ 5.90% < -1%) |
| CFO/TA 0.10 > 3% & CFO 934.1m > Net Income 339.6m |
| Net Debt (4.56b) to EBITDA (661.9m): 6.89 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.7m) vs 12m ago -1.37% < -2% |
| Gross Margin: 16.88% > 18% (prev 0.17%; Δ 1671 % > 0.5%) |
| Asset Turnover: 79.97% > 50% (prev 74.65%; Δ 5.31% > 0%) |
| Interest Coverage Ratio: 2.25 > 6 (EBITDA TTM 661.9m / Interest Expense TTM 187.4m) |
Altman Z'' 2.55
| A: 0.07 (Total Current Assets 3.11b - Total Current Liabilities 2.45b) / Total Assets 9.50b |
| B: 0.38 (Retained Earnings 3.61b / Total Assets 9.50b) |
| C: 0.05 (EBIT TTM 422.4m / Avg Total Assets 8.62b) |
| D: 0.50 (Book Value of Equity 3.61b / Total Liabilities 7.23b) |
| Altman-Z'' Score: 2.55 = A |
Beneish M -2.91
| DSRI: 1.04 (Receivables 1.50b/1.21b, Revenue 6.90b/5.78b) |
| GMI: 1.02 (GM 16.88% / 17.14%) |
| AQI: 1.00 (AQ_t 0.42 / AQ_t-1 0.42) |
| SGI: 1.19 (Revenue 6.90b / 5.78b) |
| TATA: -0.06 (NI 339.6m - CFO 934.1m) / TA 9.50b) |
| Beneish M-Score: -2.91 = A |
ValueRay F-Score (Strict, 0-100) 57.16
| 1. Piotroski: 3.50pt |
| 2. FCF Yield: 7.25% |
| 3. FCF Margin: 9.00% |
| 4. Debt/Equity: 1.92 |
| 5. Debt/Ebitda: 6.89 |
| 6. ROIC - WACC: -0.01% |
| 7. RoE: 15.86% |
| 8. Revenue Trend: 29.68% |
| 9. EPS Trend: 17.09% |
What is the price of SLGN shares?
Over the past week, the price has changed by +0.96%, over one month by +5.35%, over three months by -2.72% and over the past year by -16.20%.
Is SLGN a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SLGN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49 | 13.5% |
| Analysts Target Price | 49 | 13.5% |
| ValueRay Target Price | 42 | -2.8% |
SLGN Fundamental Data Overview January 19, 2026
P/E Forward = 11.4286
P/S = 0.7137
P/B = 1.993
P/EG = 0.8384
Revenue TTM = 6.90b USD
EBIT TTM = 422.4m USD
EBITDA TTM = 661.9m USD
Long Term Debt = 3.81b USD (from longTermDebt, last quarter)
Short Term Debt = 1.13b USD (from shortLongTermDebt, last quarter)
Debt = 4.36b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.56b USD (from netDebt column, last quarter)
Enterprise Value = 8.55b USD (4.59b + Debt 4.36b - CCE 389.2m)
Interest Coverage Ratio = 2.25 (Ebit TTM 422.4m / Interest Expense TTM 187.4m)
EV/FCF = 13.79x (Enterprise Value 8.55b / FCF TTM 620.3m)
FCF Yield = 7.25% (FCF TTM 620.3m / Enterprise Value 8.55b)
FCF Margin = 9.00% (FCF TTM 620.3m / Revenue TTM 6.90b)
Net Margin = 4.93% (Net Income TTM 339.6m / Revenue TTM 6.90b)
Gross Margin = 16.88% ((Revenue TTM 6.90b - Cost of Revenue TTM 5.73b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 16.29%)
Tobins Q-Ratio = 0.90 (Enterprise Value 8.55b / Total Assets 9.50b)
Interest Expense / Debt = 1.15% (Interest Expense 50.0m / Debt 4.36b)
Taxrate = 24.32% (36.2m / 148.7m)
NOPAT = 319.7m (EBIT 422.4m * (1 - 24.32%))
Current Ratio = 1.27 (Total Current Assets 3.11b / Total Current Liabilities 2.45b)
Debt / Equity = 1.92 (Debt 4.36b / totalStockholderEquity, last quarter 2.27b)
Debt / EBITDA = 6.89 (Net Debt 4.56b / EBITDA 661.9m)
Debt / FCF = 7.35 (Net Debt 4.56b / FCF TTM 620.3m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.94% (Net Income 339.6m / Total Assets 9.50b)
RoE = 15.86% (Net Income TTM 339.6m / Total Stockholder Equity 2.14b)
RoCE = 7.09% (EBIT 422.4m / Capital Employed (Equity 2.14b + L.T.Debt 3.81b))
RoIC = 4.68% (NOPAT 319.7m / Invested Capital 6.83b)
WACC = 4.68% (E(4.59b)/V(8.94b) * Re(8.31%) + D(4.36b)/V(8.94b) * Rd(1.15%) * (1-Tc(0.24)))
Discount Rate = 8.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.58%
[DCF Debug] Terminal Value 87.00% ; FCFF base≈619.9m ; Y1≈664.6m ; Y5≈808.7m
Fair Price DCF = 183.4 (EV 23.94b - Net Debt 4.56b = Equity 19.38b / Shares 105.7m; r=5.90% [WACC]; 5y FCF grow 8.09% → 2.90% )
EPS Correlation: 17.09 | EPS CAGR: 12.29% | SUE: 0.0 | # QB: 0
Revenue Correlation: 29.68 | Revenue CAGR: 9.30% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=-0.018 | Revisions Net=-2 | Analysts=9
EPS next Year (2026-12-31): EPS=3.81 | Chg30d=-0.046 | Revisions Net=-3 | Growth EPS=+3.3% | Growth Revenue=+2.2%
Additional Sources for SLGN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle